The Effect of LY2189265 on Insulin Secretion in Response to Intravenous Glucose Infusion.
Phase of Trial: Phase I
Latest Information Update: 01 Apr 2017
At a glance
- Drugs Dulaglutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Biomarker; Pharmacodynamics
- Sponsors Eli Lilly
- 02 Sep 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 18 Jul 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 09 Jun 2011 Planned end date changed from Jul 2011 to Aug 2011 as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History